[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Specialty Pharmaceuticals Market, by Country(US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis

August 2019 | | ID: SC760A414D7EN
Renub Research

US$ 2,395.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery, E-mail Delivery (Word)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. Specialty Pharmaceuticals considered to be more targeted drugs than traditional drugs and are also less toxic. Specialty pharmaceutical consists of products like blood-derived, biopharmaceuticals, and complex molecules. Specialty pharmaceuticals are high cost and complex drugs; the average price per patient per year for specialty medical therapy is about $35,000 to $75,000. Specialty pharmaceutical is used to treat rare diseases such as Hepatitis C, Cancer, Rheumatoid Arthritis, AIDS (Acquired Immunodeficiency Virus Syndrome), Crohn’s disease, etc. Global Specialty Pharmaceuticals Market is expected to be USD 568 Billion by 2026.

Specialty pharmacy is multiplying and becoming a significant factor for health systems and producers across the United States. The FDA approved 21 new molecular entities in the second half of 2018. Out of these products, 12 (57%) are regarded pharmaceutical specialties based on variables such as indication and designed use population, administrative and tracking considerations, price and/or restricted delivery procedures. In the last five years, United States spending on specialty drugs has almost doubled.

Renub Research report titled “Specialty Pharmaceuticals Market, by Country (United States, United Kingdom, France, Germany, Italy, Spain, Japan, South Korea), Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis, Others), Company (Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Global Analysis” provides a complete analysis of Global Specialty Pharmaceutical Market.

Oncology, Autoimmune, and Immunology are among the most significant application of global specialty pharmaceutical market

The report studies the market of the following application segments: Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis and Others. Due to the rising cases of oncology globally, Oncology is the leading application segment in this market place.

Specialty Pharmaceutical Market Share is expected to cross half of the global pharmaceutical market

Global pharmaceutical market is segmented by two types: traditional pharmaceutical and specialty pharmaceutical. At present, traditional pharmaceutical is in the dominating position across the globe, but due to increasing demands of specialty pharmaceutical products, it is anticipated that specialty pharmaceuticals will lead during the forecast period.

Company Analysis

Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals are some of the companies that deal efficiently in the specialty pharmaceuticals business. These companies have been studied thoroughly in the report.

Global Specialty Pharmaceutical Market – By Country
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • Japan
  • South Korea
Global Specialty Pharmaceutical Market – By Application
  • Oncology
  • Autoimmune
  • Immunology
  • HIV
  • Multiple Sclerosis
  • Viral Hepatitis
  • Blood Coagulation
  • Respiratory
  • Osteoporosis and
  • All Others
Global Pharmaceutical Market – By Segments
  • Global
  • Traditional
  • Specialty
Global Specialty Pharmaceutical Market – Company Covered
  • Teva Pharmaceutical
  • CVS Health
  • Endo International
  • UnitedHealth Group Incorporated
  • Recordati Pharmaceuticals
1. INTRODUCTION

2. RESEARCH & METHODOLOGY

3. EXECUTIVE SUMMARY

4. GLOBAL SPECIALTY PHARMACEUTICALS

4.1 Market
4.2 Specialty Drug Pipeline

5. MARKET SHARE – SPECIALTY PHARMACEUTICAL ANALYSIS

5.1 By Country
5.2 By Pharmaceutical Industry
5.3 By Application

6. GLOBAL PHARMACEUTICALS ANALYSIS

6.1 Total Market
6.2 Traditional Pharmaceutical Market

7. COUNTRY – SPECIALTY PHARMACEUTICAL

7.1 United States
  7.1.1 Market
  7.1.2 Specialty Drug Pipeline
7.2 Top 5 European Country
  7.2.1 Market
  7.2.2 Specialty Drug Pipeline
7.3 United Kingdom
  7.3.1 Market
  7.3.2 Specialty Drug Pipeline
7.4 France
  7.4.1 Market
  7.4.2 Specialty Drug Pipeline
7.5 Germany
  7.5.1 Market
  7.5.2 Specialty Drug Pipeline
7.6 Italy
  7.6.1 Market
  7.6.2 Specialty Drug Pipeline
7.7 Spain
  7.7.1 Market
  7.7.2 Specialty Drug Pipeline
7.8 Japan
  7.8.1 Market
  7.8.2 Specialty Drug Pipeline
7.9 South Korea
  7.9.1 Market
  7.9.2 Specialty Drug Pipeline

8. APPLICATION – SPECIALTY PHARMACEUTICAL MARKET

8.1 Oncology
8.2 Autoimmune
8.3 Immunology
8.4 HIV
8.5 Multiple Sclerosis (MS)
8.6 Viral Hepatitis
8.7 Blood Coagulation
8.8 Respiratory
8.9 Osteoporosis
8.10 All Others

9. MARKET DYNAMICS

9.1 Growth Drivers
  9.1.1 Improving Life Expectancy
  9.1.2 Surge in Spending on Medicines
  9.1.3 Prevalence of Chronic Disease
9.2 Key Challenges
  9.2.1 Abandonment Rates for Specialty Medicines & High R&D Costs

10. TREND AND OPPORTUNITIES

10.1 Trends
  10.1.1 Increased Spending on Specialty Pharmacy
  10.1.2 A Generic Wave of Specialty Drugs
  10.1.3 An Ever-expanding Pipeline of Products
  10.1.4 Targeted Therapies to Emerge
  10.1.5 Healthcare Reforms to Take Control
  10.1.6 Growth of Co-Pay Programs
  10.1.7 Medication Therapy Management (MTM) will Advance
  10.1.8 Specialty Prescribing to Rise
  10.1.9 Real-Time Pharmacy Benefit
10.2 Opportunities
  10.2.1 Leverage the Changing Face of Specialty Pharmacy Industry with Flat world Solutions

11. SPECIALTY PHARMACY MERGERS AND ACQUISITIONS

12. COMPANY ANALYSIS

12.1 Teva Pharmaceutical Industries Ltd
  12.1.1 Overview
  12.1.2 Recent Developments
  12.1.3 Revenue
12.2 CVS Health
  12.2.1 Overview
  12.2.2 Recent Developments
  12.2.3 Revenue
12.3 Endo International Specialty Products
  12.3.1 Overview
  12.3.2 Recent Developments
  12.3.3 Revenue
12.4 UnitedHealth Group Incorporated
  12.4.1 Overview
  12.4.2 Recent Developments
  12.4.3 Revenue
12.5 Recordati Pharmaceuticals Ltd
  12.5.1 Overview
  12.5.2 Recent Developments
  12.5.3 Revenue

13. CONCLUSION

LIST OF FIGURES:

Figure-01: Global - Specialty Market (Million US$), 2015 – 2018
Figure-02: Global - Forecast For Specialty Market (Million US$), 2019 – 2026
Figure-03: Global - Pharmaceutical Market Share By Segment (Percent), 2015 – 2018
Figure-04: Global - Forecast for Pharmaceutical Market Share by Segment (Percent), 2019 – 2026
Figure-05: Global - Pharmaceutical market (Million US$), 2015 – 2018
Figure-06: Global - Pharmaceutical Forecast for market (Million US$), 2019 – 2026
Figure-07: Global - Traditional Pharmaceutical Market (Million US$), 2015 – 2018
Figure-08: Global - Forecast For Traditional Pharmaceutical Market (Million US$), 2019 – 2026
Figure-09: United States - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-10: United States - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-11: Top 5 European Countries - Specialty Pharmaceutical market (Billion US$) 2015 - 2018
Figure-12: Top 5 European Countries – Forecast for Specialty Pharmaceutical market (Billion US$) 2019 - 2026
Figure-13: United Kingdom - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-14: United Kingdom – Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-15: France - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-16: France - Forecast For Specialty Pharmaceutical market (Million US$), ) 2019 – 2026
Figure-17: Germany - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-18: Germany - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-19: Italy - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-20: Italy - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-21: Spain - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-22: Spain - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-23: Japan - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-24: Japan - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-25: South Korea - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-26: South Korea - Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-27: By Application - Oncology Market (Million US$), 2015 – 2018
Figure-28: Forecast for by Application Oncology Market (Million US$), 2019 – 2026
Figure-29: Application - Autoimmune Market (Million US$), 2015 – 2018
Figure-30: Application - Forecast for Autoimmune Market (Million US$), 2019 – 2026
Figure-31: Application - Immunology Market (Million US$), 2015 – 2018
Figure-32: Application - Forecast for Immunology Market (Million US$), 2019 – 2026
Figure-33: Application - Human Immunodeficiency Virus Market (Million US$), 2015 – 2018
Figure-34: Application - Forecast for Human Immunodeficiency Virus Market (Million US$), 2019 – 2026
Figure-35: By Application - Multiple Sclerosis (MS) Market (Million US$), 2015 – 2018
Figure-36: Forecast for by Application - Multiple Sclerosis (MS) Market (Million US$), 2019 – 2026
Figure-37: Application - Viral Hepatitis Market (Million US$), 2015 – 2018
Figure-38: Application - Forecast for Viral Hepatitis Market (Million US$), 2019 – 2026
Figure-39: Application - Blood Coagulation Market (Million US$), 2015 – 2018
Figure-40: Application - Forecast for Blood Coagulation Market (Million US$), 2019 – 2026
Figure-41: Application - Respiratory Market (Million US$), 2015 – 2018
Figure-42: Application - Forecast for Respiratory Market (Million US$), 2019 – 2026
Figure-43: Application - Osteoporosis Market (Million US$), 2015 – 2018
Figure-44: Application - Forecast for Osteoporosis Market (Million US$), 2019 – 2026
Figure-45: Application - All Others Market (Million US$), 2015 – 2018
Figure-46: Application - Forecast for All Others Market (Million US$), 2019 – 2026
Figure-47: Percentage of Global R&D Spending - by Pharma Companies
Figure-48: Teva Pharmaceutical Industries Ltd - Revenue (Million US$), 2014 – 2018
Figure-49: Teva Pharmaceutical Industries Ltd - Forecast for Revenue (Million US$), 2019 – 2026
Figure-50: CVS Health Revenue Market (Million US$), 2014 – 2018
Figure-51: Forecast for CVS Health Revenue Market (Million US$), 2019 – 2026
Figure-52: Endo International Specialty Products - Revenue (Million US$), 2014 – 2018
Figure-53: Endo International Specialty Products - Forecast for Revenue (Million US$), 2019 – 2026
Figure-54: UnitedHealth Group Incorporated - Revenue (Million US$), 2014 – 2018
Figure-55: UnitedHealth Group Incorporated - Forecast for Revenue (Million US$), 2019 – 2026
Figure-56: Recordati Pharmaceuticals Ltd - Revenue (Million US$), 2014 – 2018
Figure-57: Recordati Pharmaceuticals Ltd - Forecast for Revenue (Million US$), 2019 – 2026

LIST OF TABLES:

Figure-01: Global Specialty Drug Pipeline
Figure-02: Global - Specialty Pharmaceutical Market Share By Country (Percent), 2015 – 2018
Figure-03: Global - Forecast For Specialty Pharmaceutical Market Share By Country (Percent), 2019 – 2026
Figure-04: Global - Specialty Pharmaceutical Market Share By Application (Percent), 2015 – 2018
Figure-05: Global - Forecast for Specialty Pharmaceutical Market Share By Application (Percent), 2019 – 2026
Figure-06: United States – Companies Specialty Drug/R&D Pipeline
Figure-07: Shire Specialty Drug Pipeline
Figure-08: Meldex international Clinical Trial
Figure-09: Therapeutics: focus on the Italian pipeline
Figure-10: Orphan Drugs and Advanced Therapies
Figure-11: Bioneer Corporation - Research & Development Pipeline
Figure-12: CORESTEM Inc - Research & Development Pipeline of
Figure-13: Crystal Genomics, Inc - Research & Development Pipeline
Figure-14: Genexine - Research & Development Pipeline
Figure-15: ViroMed Co. – Representative Product – Biologics (Clinical Trial)
Figure-16: Bcworld Pharm. Co., Ltd. – Main Products
Figure-17: Bcworld Pharm. Co., Ltd – R&D Pipeline


More Publications